Healthcare provider profile · identity verified

Larry A Henderson, MD

Allopathic & Osteopathic Physicians|Family Medicine · LUCEDALE, MS · NPI 1215976022

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Larry A Henderson, MD received $152.44 in general payments during 2025 across 10 reported records.

Novo Nordisk Inc accounted for 28.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Xifaxan.

Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Prolia by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 199 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Rybelsus by this doctor in 2024.

Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIFAXAN as an associated drug or biological on 101901 records involving 33018 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Xifaxan by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$152.44

10 reported records · 6 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$43.97	28.8%	3	2025
Salix Pharmaceuticals, a division of Bausch Health US, LLC	Unresolved — no canonical attribution shown	$42.34	27.8%	2	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$19.26	12.6%	1	2025
Axsome Therapeutics, Inc.	Unresolved — no canonical attribution shown	$18.51	12.1%	1	2025
Paratek Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$17.38	11.4%	1	2025
Phathom Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$10.98	7.2%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$152.44	10

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
XIFAXAN Normalized: xifaxan	Drug	Salix Pharmaceuticals, a division of Bausch Health US, LLC	$42.34	2	2025
Source payment records 2025-02-05 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $19.13 · Open Payments source 2025-06-03 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $23.21 · Open Payments source
EVENITY Normalized: evenity	Biological	Amgen Inc.	$19.26	1	2025
Source payment records 2025-12-01 · Amgen Inc. · $19.26 · Open Payments source
Sunosi Normalized: sunosi	Drug	Axsome Therapeutics, Inc.	$18.51	1	2025
Source payment records 2025-01-06 · Axsome Therapeutics, Inc. · $18.51 · Open Payments source
NUZYRA Normalized: nuzyra	Drug	Paratek Pharmaceuticals, Inc.	$17.38	1	2025
Source payment records 2025-08-18 · Paratek Pharmaceuticals, Inc. · $17.38 · Open Payments source
VOQUEZNA Normalized: voquezna	Drug	Phathom Pharmaceuticals, Inc.	$10.98	2	2025
Source payment records 2025-10-27 · Phathom Pharmaceuticals, Inc. · $0.38 · Open Payments source 2025-10-30 · Phathom Pharmaceuticals, Inc. · $10.60 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
XIFAXAN xifaxan	2025	Xifaxan	2024	11 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Amgen Inc. Exact reporting entity; no affiliate inference	2025	PROLIA open payments reported associated product	CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448	Prolia · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	199	49
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference	2025	XIFAXAN open payments reported associated product	CMS Open Payments — General Payments 101901 supporting records · 33018 recipient NPIs · example record 1231775337	Xifaxan · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	888	147
Gabapentin	Gabapentin	845	224
Omeprazole	Omeprazole	799	191
Lisinopril	Lisinopril	697	168
Rosuvastatin Calcium	Rosuvastatin Calcium	687	168
Atorvastatin Calcium	Atorvastatin Calcium	684	163
Amlodipine Besylate	Amlodipine Besylate	660	161
Metformin Hcl	Metformin Hcl	582	137
Levothyroxine Sodium	Levothyroxine Sodium	552	126
Potassium Chloride	Potassium Chloride	530	132
Furosemide	Furosemide	502	141
Losartan Potassium	Losartan Potassium	471	116
Trazodone Hcl	Trazodone Hcl	462	119
Pantoprazole Sodium	Pantoprazole Sodium	427	104
Metoprolol Succinate	Metoprolol Succinate	413	97
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	392	88
Tamsulosin Hcl	Tamsulosin Hcl	360	107
Carvedilol	Carvedilol	347	90
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	323	66
Meloxicam	Meloxicam	318	93
Buspirone Hcl	Buspirone Hcl	286	65
Metoprolol Tartrate	Metoprolol Tartrate	273	63
Clopidogrel	Clopidogrel Bisulfate	270	66
Cefdinir	Cefdinir	265	205
Albuterol Sulfate Hfa	Albuterol Sulfate	254	67
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	251	55
Doxycycline Hyclate	Doxycycline Hyclate	248	198
Duloxetine Hcl	Duloxetine Hcl	241	46
Montelukast Sodium	Montelukast Sodium	240	55
Simvastatin	Simvastatin	234	47
Escitalopram Oxalate	Escitalopram Oxalate	226	59
Sucralfate	Sucralfate	225	65
Tizanidine Hcl	Tizanidine Hcl	220	66
Allopurinol	Allopurinol	218	55
Fluticasone Propionate	Fluticasone Propionate	218	82
Sertraline Hcl	Sertraline Hcl	216	47
Glimepiride	Glimepiride	215	46
Ozempic	Semaglutide	199	49
Hydrochlorothiazide	Hydrochlorothiazide	197	60
Tramadol Hcl	Tramadol Hcl	187	62
Pravastatin Sodium	Pravastatin Sodium	183	40
Prednisone	Prednisone	176	93
Pregabalin	Pregabalin	175	45
Famotidine	Famotidine	164	58
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	150	32
Fluconazole	Fluconazole	143	97
Amitriptyline Hcl	Amitriptyline Hcl	142	26
Linzess	Linaclotide	141	39
Esomeprazole Magnesium	Esomeprazole Magnesium	135	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	133	50
Clonidine Hcl	Clonidine Hcl	132	55
Zolpidem Tartrate	Zolpidem Tartrate	123	23
Citalopram Hbr	Citalopram Hydrobromide	122	28
Ciprofloxacin Hcl	Ciprofloxacin Hcl	119	97
Alendronate Sodium	Alendronate Sodium	117	32
Xarelto	Rivaroxaban	116	19
Donepezil Hcl	Donepezil Hcl	113	27
Alprazolam	Alprazolam	111	25
Celecoxib	Celecoxib	109	36
Quetiapine Fumarate	Quetiapine Fumarate	109	25
Mirtazapine	Mirtazapine	108	24
Amoxicillin	Amoxicillin	106	85
Glipizide	Glipizide	106	25
Metformin Hcl Er	Metformin Hcl	105	32
Oxybutynin Chloride Er	Oxybutynin Chloride	99	28
Azithromycin	Azithromycin	97	79
Finasteride	Finasteride	97	27
Trulicity	Dulaglutide	96	21
Januvia	Sitagliptin Phosphate	95	17
Baclofen	Baclofen	93	22
Hydroxyzine Hcl	Hydroxyzine Hcl	87	34
Eliquis	Apixaban	86	22
Ondansetron Odt	Ondansetron	86	57
Ondansetron Hcl	Ondansetron Hcl	85	34
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	80	61
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	79	15
Meclizine Hcl	Meclizine Hcl	76	47
Methocarbamol	Methocarbamol	75	44
Primidone	Primidone	75	16
Jardiance	Empagliflozin	74	24
Ezetimibe	Ezetimibe	73	18
Symbicort	Budesonide/Formoterol Fumarate	71	19
Bupropion Xl	Bupropion Hcl	70	12
Clindamycin Hcl	Clindamycin Hcl	70	61
Ibuprofen	Ibuprofen	70	25
Promethazine Hcl	Promethazine Hcl	69	24
Synthroid	Levothyroxine Sodium	68	17
Doxepin Hcl	Doxepin Hcl	67	15
Fluoxetine Hcl	Fluoxetine Hcl	67	17
Pioglitazone Hcl	Pioglitazone Hcl	67	20
Ropinirole Hcl	Ropinirole Hcl	66	14
Topiramate	Topiramate	66	11
Aripiprazole	Aripiprazole	64	12
Hydralazine Hcl	Hydralazine Hcl	64	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	21
Triamcinolone Acetonide	Triamcinolone Acetonide	63	47
Warfarin Sodium	Warfarin Sodium	63	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	62	40
Levofloxacin	Levofloxacin	61	52
Memantine Hcl	Memantine Hcl	61	13
Estradiol	Estradiol	59	14
Torsemide	Torsemide	59	18
Amiodarone Hcl	Amiodarone Hcl	58	15
Paroxetine Hcl	Paroxetine Hcl	54	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	52	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	51	39
Spironolactone	Spironolactone	49	16
Diclofenac Sodium	Diclofenac Sodium	47	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	12
Benazepril Hcl	Benazepril Hcl	46	12
Nifedipine Er	Nifedipine	45	suppressed
Azelastine Hcl	Azelastine Hcl	43	20
Oxybutynin Chloride	Oxybutynin Chloride	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	34
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	39	suppressed
Atenolol	Atenolol	39	suppressed
Ramipril	Ramipril	39	suppressed
Propranolol Hcl	Propranolol Hcl	38	suppressed
Diazepam	Diazepam	37	suppressed
Lovastatin	Lovastatin	37	11
Dicyclomine Hcl	Dicyclomine Hcl	36	13
Lamotrigine	Lamotrigine	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Ventolin Hfa	Albuterol Sulfate	36	11
Benztropine Mesylate	Benztropine Mesylate	35	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	35	suppressed
Midodrine Hcl	Midodrine Hcl	35	suppressed
Ofloxacin	Ofloxacin	35	34
Gemfibrozil	Gemfibrozil	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	suppressed
Testosterone Cypionate	Testosterone Cypionate	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	31	11
Lorazepam	Lorazepam	31	suppressed
Nystatin	Nystatin	31	16
Acyclovir	Acyclovir	30	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	30	22
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	29	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	29	suppressed
Mupirocin	Mupirocin	29	23
Divalproex Sodium	Divalproex Sodium	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	15
Nitroglycerin	Nitroglycerin	26	12
Alfuzosin Hcl Er	Alfuzosin Hcl	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Naproxen	Naproxen	25	13
Bumetanide	Bumetanide	24	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Valsartan	Valsartan	24	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	23	suppressed
Colchicine	Colchicine	23	13
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Nebivolol Hcl	Nebivolol Hcl	23	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	22	suppressed
Febuxostat	Febuxostat	22	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Movantik	Naloxegol Oxalate	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Cephalexin	Cephalexin	20	13
Megestrol Acetate	Megestrol Acetate	20	11
Tresiba Flextouch U-200	Insulin Degludec	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	19	suppressed
Risperidone	Risperidone	19	suppressed
Novolog	Insulin Aspart	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Desloratadine	Desloratadine	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Novolin R	Insulin Regular, Human	16	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Verapamil Hcl	Verapamil Hcl	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	13
Methotrexate	Methotrexate Sodium	15	suppressed
Propafenone Hcl	Propafenone Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Tiagabine Hcl	Tiagabine Hcl	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Olanzapine Odt	Olanzapine	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	13	12
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Felodipine Er	Felodipine	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	11	suppressed
Chlorzoxazone	Chlorzoxazone	11	suppressed
Colesevelam Hcl	Colesevelam Hcl	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Invokana	Canagliflozin	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Prolia	Denosumab	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$152.44 · 10 records	Novo Nordisk Inc	EVENITY, NUZYRA, Sunosi, VOQUEZNA, XIFAXAN	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Xifaxan play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error